Daniel Lee

Daniel Lee is an accomplished executive with extensive experience in the life sciences, pharmaceuticals, and consulting sectors. Currently serving as Vice President of Enterprise Strategy and Portfolio Analytics at Alnylam Pharmaceuticals, Daniel has previously held senior roles at Helix, CVS Health, Cadsley Consulting Group, and Pfizer, where significant achievements include launching new businesses, leading enterprise modernization initiatives, and transforming underperforming teams into high-impact consulting operations. Notable contributions include generating substantial revenue increases, overseeing major acquisitions, and successfully operationalizing a new $9 billion division at Pfizer. Daniel holds an MBA in Finance from NYU Stern School of Business, a Master of Science in Engineering Mechanics from Penn State University, and a Bachelor of Science in Mechanical Engineering from the University of Michigan.